Additional regulations None Idaho Who can prescribe semaglutide
Here's how they compare: Semaglutide (GLP-1 agonist) Mechanism: Single-action GLP-1 receptor agonist FDA status: Approved for type 2 diabetes and chronic weight management Expected weight loss: 15-20% of body weight in clinical trials Administration: Once-weekly injection Best for: Patients starting their weight loss journey seeking proven, well-studied medication Tirzepatide (dual GIP/GLP-1 agonist) Mechanism: Targets both GIP and GLP-1 receptors for enhanced metabolic effect FDA status: Approved for type 2 diabetes and chronic weight management Expected weight loss: Up to 22% of body weight in clinical trials Administration: Once-weekly injection Best for: Patients seeking more aggressive fat loss with dual-action metabolic support Retatrutide (triple agonist, not yet available) Mechanism: Targets GLP-1, GIP, and glucagon receptors FDA status: Not FDA-approved
Visit megaphone.fm/adchoices Day 304 Essentials: Food & Supplements for Brain Health & Cognitive Performance In this Huberman Lab Essentials episode, I discuss science-supported nutrients that directly support brain structure, function and long-term cognitive health
A daily fluid intake of approximately 23 L is advised, prioritising water and hydrating foods while limiting alcohol, caffeinated beverages, and sugary drinks [88, 89]
The sensitivity started a bit after starting Ozempic and stopped right after I stopped taking it, so it was that for sure
